Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We’re delighted to announce that the Director of the Oxford BHF Centre of Research Excellence, Prof Hugh Watkins, has been elected a Fellow of the Royal Society. This is a very prestigious honour and one that recognises Hugh’s pioneering heart disease work and commitment to scientific research.

Hugh Watkins is a physician scientist whose work has helped reveal the genetic basis of inherited heart diseases and has led to new approaches to diagnosis and therapy with substantial benefit to patients. 

His work on hypertrophic cardiomyopathy showed that this common, life-threatening, heart muscle disorder is caused by mutations in the molecular motor proteins of the heart. These findings highlighted novel aspects of muscle physiology and cardiac energetics, opening the way to new approaches to therapy. He went on to develop direct genetic testing and show its clinical utility for identifying individuals at risk; adoption of genetic testing has transformed clinical care for affected families worldwide. 

The Fellowship of the Royal Society is made up of the most eminent scientists, engineers and technologists from or living and working in the UK and the Commonwealth. Hugh joins an impressive roster of researchers past and present.

Congratulations to Hugh on this well-deserved achievement. 

You can read more about this year’s elected Fellows on the Royal Society website.

Similar stories

Genetic breakthrough to target care for deadly heart condition

CRE Research

Professor Watkins and his team have found a new type of genetic change in the DNA of people with hypertrophic cardiomyopathy (HCM) - a silent killer amongst families that can cause sudden death in young people due to the thickening of the heart muscle.

Earliest origins of the forming heart identified

CRE Research

The earliest known progenitor of the outermost layer of the heart has been characterised for the first time and linked to the development of other critical cell types in the developing heart in a new paper from the Srinivas group led by BHF Immediate Fellow Dr Richard Tyser.

Professor Sir Rory Collins awarded the MRC Millennium Medal 2020

CRE Research

Professor Sir Rory Collins, Head of the Nuffield Department of Population Health, and Principal Investigator and Chief Executive of UK Biobank, has been awarded the Medical Research Council (MRC) Millennium Medal 2020, the MRC’s most prestigious personal award.

New MRI technique could detect early signs of heart failure in cancer patients following chemotherapy

CRE Publication Research

New research led by Oxford BHF CRE Intermediate Transition Fellow Dr Kerstin Timm shows that a recently developed imaging technique pioneered by the Tyler Group can detect early metabolic changes in the heart caused by a commonly used chemotherapy drug, which is known to increase risk of heart failure in cancer survivors.

Two major BHF awards to Neil Herring pave the way to new treatments for heart attack patients

CRE Research

Associate Professor Neil Herring has been awarded a Senior Clinical Research Fellowship and a Project grant from the British Heart Foundation to further critical research into the mechanisms behind heart attacks and heart failure and potential drugs to combat them. Given the 50% reduction in research investment this year from the BHF due to the impact of COVID-19, Prof Herring is to be congratulated on these awards.